Paper Details

  1. Home
  2. Paper Details

Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study.

Author: , ForderPeta, HagueWendy, HuntDavid, SimesJohn, TonkinAndrew

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Controlled Clinical TrialA clinical trial that evaluates the effectiveness of a treatment by comparing a group that receives the intervention with a group that receives a placebo or standard treatment.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This subgroup analysis of the LIPID study showed that pravastatin prevented further events in women with coronary heart disease and average cholesterol levels.
Paper Details　
Original Abstract of the Article :
The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) study showed that cholesterol-lowering therapy prevented further events in patients with coronary heart disease and average cholesterol levels. The aim of this subgroup analysis was to assess the effects of pravastatin in women...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/12679760

データ提供：米国国立医学図書館（NLM）

Pravastatin for Women with Coronary Heart Disease: A Path Through the Desert

This subgroup analysis of the LIPID study investigates the effects of pravastatin, a cholesterol-lowering medication, on cardiovascular events and mortality in women with coronary heart disease (CHD). CHD is a leading cause of death in women, and the study aimed to assess the potential benefits of pravastatin in reducing the risk of further cardiovascular events in this population. The findings suggest that pravastatin can significantly reduce the risk of cardiovascular events in women with CHD, offering a valuable tool for managing this challenging condition.

Protecting Women's Heart Health: A Desert Oasis of Knowledge

The study's findings emphasize the importance of managing cholesterol levels in women with CHD. Pravastatin, a cholesterol-lowering medication, was found to be effective in reducing the risk of further cardiovascular events in this population. This research offers a beacon of hope in the desert of cardiovascular disease, reminding us that managing cholesterol levels is crucial for protecting the health of women's hearts.

Heart Health: A Journey Through the Desert

This research highlights the importance of managing cholesterol levels in women with CHD. The findings underscore the effectiveness of pravastatin in reducing the risk of further cardiovascular events in this population. The study reminds us that maintaining a healthy lifestyle, including regular exercise, a balanced diet, and managing cholesterol levels, is essential for protecting heart health.

Dr.Camel's Conclusion

This subgroup analysis of the LIPID study investigates the effects of pravastatin on cardiovascular events and mortality in women with coronary heart disease. The findings demonstrate the effectiveness of pravastatin in reducing the risk of further cardiovascular events in this population, highlighting its importance in managing CHD in women.
Date :
  1. Date Completed 2003-05-01
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

12679760

DOI: Digital Object Identifier

S0002870302947101

Related Literature

Article Analysis
・Effects of pravastatin
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.